Some of these resultant compounds would normally be unstable
Genetic modulation offers high target specificity but faces delivery and safety hurdles
Now its become our go-to for game day parties, potluck dinners, and holiday gatherings
triplex proteins 1 and 2 (TRI-1 and TRI-2, respectively) forming heterotrimers in a 1:2 ratio to connect the capsomers
Eosinophilic Gastrointestinal Disease (EGID) Research What research is being done to prevent EGIDs? There are four stages of disease prevention: Reducing risk factors for all patients. Preventing EGIDs in healthy, but susceptible patients. Identifying patients who have early signs of EGIDs without symptoms. Reducing disease severity in patients diagnosed with EGIDs. The increase in EGIDs is likely due to a combination of factors including specific exposures, patient characteristics, and the environment. Potential early life exposures may include prematurity, cesarean section delivery, lack of breastfeeding, and acid blocker or antibiotic use in infancy. Patient factors include other allergic diseases, poor esophageal barrier function, and increased susceptibility to inflammation and scarring. Potential environmental factors include cold, arid climates. Future studies are needed to identify cause and effect relationships between these factors and the development of EGIDs. Are access to healthcare and socioeconomic factors being studied in EGIDs? Existing data is limited, but some tools are available to evaluate how socioeconomic factors and access to healthcare affect EGID care. The Childhood Opportunity Index (COI) measures and maps the quality of resources and conditions that matter for children to develop in a healthy way in the neighborhoods where they live. The COI has been used to study pediatric asthma
